Minerva Neurosciences, Inc (NERV) Financials

NERV Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 56.9 billion 85.4 billion
2023-09-30 63.1 million 83.2 million
2023-06-30 67.1 million 79.6 million
2023-03-31 51.6 million 78.2 million

NERV Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.0 million 611064
2023-09-30 -6.9 million 371943
2023-06-30 -3.9 million 608915
2023-03-31 -115407 376459

NERV Net Income

No data available :(

NERV Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 40.9 billion - -
2023-09-30 46.9 million - -
2023-06-30 51.8 million - -
2023-03-31 36.0 million - -

NERV Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 6.5 million
2023-09-30 7.6 million
2023-06-30 5.5 million
2023-03-31 5.3 million

NERV Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 4.7 million 2.5 million -7746
2023-09-30 - 3.4 million 2.6 million -
2023-06-30 - 1.9 million 2.6 million -
2023-03-31 - 2.7 million 2.7 million -

NERV Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 7746
2023-09-30 - 7745
2023-06-30 - 7746
2023-03-31 - 7745

NERV

Price: $2.37

52 week price:
1.90
13.49

Payout Ratio Range:
-45.96%
-13.68%

Earnings Per Share: -4.61 USD

P/E Ratio: -1.89

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 48300

Ebitda: -11.1 million

Market Capitalization: 17.8 million

Links: